Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
ACS Chemical Neuroscience|May 29, 2014
Terpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systemsDavid R Janero, Alexandros Makriyannis
Current Psychiatry Reports|October 5, 2007
Targeted modulators of the endogenous cannabinoid system: future medications to treat addiction disorders and obesityDavid R Janero, Alexandros Makriyannis
Expert Opinion on Drug Discovery|October 8, 2016
Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery targetDavid R Janero, Ganesh A Thakur
Methods in Enzymology|July 29, 2017
Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding DomainsDavid R Janero, Anisha Korde, Alexandros Makriyannis
Nanomedicine : Nanotechnology, Biology, and Medicine|March 12, 2013
Engineering of an ω-3 polyunsaturated fatty acid-containing nanoemulsion system for combination C6-ceramide and 17β-estradiol delivery and bioactivity in human vascular endothelial and smooth muscle cellsDipti Deshpande, David R Janero, Mansoor Amiji
International Review of Psychiatry (Abingdon, England)|April 16, 2009
Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategiesDavid R Janero, Subramanian K Vadivel, Alexandros Makriyannis
Physiology & Behavior|December 25, 2007
Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndromeV Kiran Vemuri, David R Janero, Alexandros Makriyannis
Biochemical Pharmacology|November 29, 2016
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targetsSrikrishnan Mallipeddi, David R Janero, Nikolai Zvonok, et al.
Expert Opinion on Biological Therapy|October 14, 2011
Therapeutic strategies for endothelial dysfunctionDipti D Deshpande, David R Janero, Mansoor M Amiji
Plos One|February 4, 2016
Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental AtherosclerosisDipti Deshpande, Sravani Kethireddy, David R Janero, et al.
Pageof 7